Dehydro silodosin

• Description:

  Dehydro silodosin (KMD-3241) is a selective α1A-adrenoceptor antagonist used in the study of benign prostatic hyperplasia[1].

• Product Name Alternative:

  KMD-3241

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H315-H319-H335

• Target:

  Adrenergic Receptor

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Field of Research:

  Cancer

• Smiles:

  OCCCN1C2=C (C (N) =O) C=C (C[C@@H] (C) NCCOC3=C (C=CC=C3) OCC (F) (F) F) C=C2C=C1

• Molecular Formula:

  C25H30F3N3O4

• Molecular Weight:

  493.52

• Precautions:

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations:

  [1]Yoshida M, et al. Silodosin, a novel selective α1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia. Expert opinion on investigational drugs, 2007, 16 (12) : 1955-1965.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound2

• Clinical Information:

  No Development Reported

• CAS Number:

  175870-21-0